Pfizer might be able to identify potential safety issues of drug candidates in early stages, as it has licensed a human cell line from Absorption Systems designed to do just that. What Pfizer has an ...
Beijing-based contract research and manufacturing company Pharmaron is paying $137.5 million in cash to buy up nonclinical CRO Absorption Systems. This sees the publicly listed Chinese CRMO broaden ...
BEIJING--(BUSINESS WIRE)--Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”), a fully integrated contract research and manufacturing organization offering laboratory, CMC and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results